‘CASCADE’ Network Organizational Units

The ‘CASCADE’ Network consists of the following organizational units: one Network Coordinating Center (supported via RFA-CA-21-045), three Research Bases (supported via RFA-CA-21-046), and eight Clinical Sites (three sites supported via RFA-CA-21-047; five additional sites to be supported via RFA-CA-22-051 in 2023).

Organizational Unit Principal Investigator(s) Institution(s) Grant No.
CASCADE Network Coordinating Center (CNCC) Suzanne Siminski, M.S., M.B.A., KyungMann Kim, Ph.D., and Anna-Barbara Moscicki, M.D. Frontier Science, with
University of Wisconsin and
University of California, Los Angeles
U24CA275417
Research Base 1 (RB1) Rachel Winer, Ph.D., M.P.H. and
Elizabeth Brown, Sc.D., M.S.
University of Washington, with
Fred Hutchinson Cancer Research Center
UG1CA275402
Research Base 2 (RB2) Timothy Wilkin, M.D., M.P.H., Anna Giuliano, Ph.D., and
Carla Chibwesha, M.D., M.Sc.
Weill Medical College of Cornell University, with Moffitt Cancer Center and University of North Carolina at Chapel Hill UG1CA275414
Research Base 3 (RB3) Jennifer Smith, Ph.D., M.P.H., Michael Hudgens, Ph.D., and Lameck Chinula, M.D., M.P.H. University of North Carolina at Chapel Hill UG1CA275403
Clinical Trials Site 1 (CS1): Uganda Betty Mwesigwa, M.B.Ch.B., M.Sc. Makerere University Walter Reed Project, with US Military HIV Research Program and Uganda Cancer Institute UG1CA275412
Clinical Trials Site 2 (CS2): Kenya Michael Chung, M.D., Ph.D., M.P.H. and Samah Sakr, M.B.Ch.B. Emory University, with Coptic Hope Center for Infectious Diseases and Kenyatta National Hospital UG1CA275400
Clinical Trials Site 3 (CS3): Botswana Scott Dryden-Peterson, M.D., M.S. and Doreen Ramogola-Masire, M.B.B.S., Ph.D., M.P.H. Brigham and Women's Hospital, with Botswana Harvard AIDS Institute Partnership UG1CA275416